Roddy Mitchell, A. et al. Prevalence of perinatal depression in low- and middle-income countries: a systematic review and meta-analysis. JAMA Psychiatry 80, 425–431 (2023).
Google Scholar
Howard, L. M. et al. Non-psychotic mental disorders in the perinatal period. Lancet 384, 1775–1788 (2014).
Google Scholar
Cameron, E. E., Sedov, I. D. & Tomfohr-Madsen, L. M. Prevalence of paternal depression in pregnancy and the postpartum: an updated meta-analysis. J. Affect. Disord. 206, 189–203 (2016).
Google Scholar
Slomian, J., Honvo, G., Emonts, P., Reginster, J.-Y. & Bruyère, O. Consequences of maternal postpartum depression: a systematic review of maternal and infant outcomes. Womens Health 15, 1745506519844044 (2019).
Vacheron, M. N., Tessier, V., Rossignol, M. & Deneux-Tharaux, C. Comité National d’Experts sur la Mortalité Maternelle Maternal deaths due to suicide in France 2013–2015. Gynecol. Obstet. Fertil. Senol. 49, 38–46 (2021).
Google Scholar
Lindahl, V., Pearson, J. L. & Colpe, L. Prevalence of suicidality during pregnancy and the postpartum. Arch. Womens. Ment. Health 8, 77–87 (2005).
Google Scholar
Grigoriadis, S. et al. Perinatal suicide in Ontario, Canada: a 15-year population-based study. CMAJ 189, E1085–E1092 (2017).
Google Scholar
Lewis, G., Neary, M., Polek, E., Flouri, E. & Lewis, G. The association between paternal and adolescent depressive symptoms: evidence from two population-based cohorts. Lancet Psychiatry 4, 920–926 (2017).
Google Scholar
Molenaar, N. M. et al. The international prevalence of antidepressant use before, during, and after pregnancy: a systematic review and meta-analysis of timing, type of prescriptions and geographical variability. J. Affect. Disord. 264, 82–89 (2020).
Google Scholar
Andrade, S. E. et al. Use of selective serotonin reuptake inhibitors (SSRIs) in women delivering liveborn infants and other women of child-bearing age within the US Food and Drug Administration’s Mini-Sentinel program. Arch. Womens. Ment. Health 19, 969–977 (2016).
Google Scholar
Whitaker-Azmitia, P. M. Serotonin and brain development: role in human developmental diseases. Brain Res. Bull. 56, 479–485 (2001).
Google Scholar
Misri, S., Burgmann, A. & Kostaras, D. Are SSRIs safe for pregnant and breastfeeding women? Can. Can. Fam. Physician 46, 626–633 (2000).
Google Scholar
Pawluski, J. L., Li, M. & Lonstein, J. S. Serotonin and motherhood: from molecules to mood. Front. Neuroendocrinol. 53, 100742 (2019).
Google Scholar
St-Pierre, J., Laurent, L., King, S. & Vaillancourt, C. Effects of prenatal maternal stress on serotonin and fetal development. Placenta 48, S66–S71 (2016).
Google Scholar
Oberlander, T. F. & Zwaigenbaum, L. Disentangling maternal depression and antidepressant use during pregnancy as risks for autism in children. JAMA 317, 1533–1534 (2017).
Google Scholar
Liu, X. et al. Antidepressant discontinuation before or during pregnancy and risk of psychiatric emergency in Denmark: a population-based propensity score-matched cohort study. PLoS Med. 19, e1003895 (2022).
Google Scholar
Trinh, N. T. H. et al. Timing of antidepressant discontinuation during pregnancy and postpartum psychiatric outcomes in Denmark and Norway. JAMA Psychiatry 80, 441–450 (2023).
Google Scholar
Vigod, S. N. et al. Canadian Network for Mood and Anxiety Treatments 2024 Clinical Practice Guideline for the Management of Perinatal Mood, Anxiety, and Related Disorders: Guide de pratique 2024 du Canadian Network for Mood and Anxiety Treatments pour le traitement des troubles de l’humeur, des troubles anxieux et des troubles connexes perinatals. Can. J. Psychiatry 70, 429–489 (2025).
Google Scholar
Pratt, L. A., Brody, D. J. & Gu, Q. Antidepressant use among persons aged 12 and over: United States, 2011–2014 (NCHS, 2017).
Wisner, K. L. et al. in Gabbe’s Obstetrics: Normal and Problem Pregnancies (eds Landon, M. B. et al.) Ch. 59 (Elsevier, 2024).
Wogelius, P. et al. Maternal use of selective serotonin reuptake inhibitors and risk of congenital malformations. Epidemiology 17, 701–704 (2006).
Google Scholar
Rommel, A. S., Bergink, V., Liu, X., Munk-Olsen, T. & Molenaar, N. M. Long-term effects of intrauterine exposure to antidepressants on physical, neurodevelopmental, and psychiatric outcomes: a systematic review. J. Clin. Psychiatry 81, 19r12965 (2020).
Google Scholar
Christensen, J., Trabjerg, B. B., Sun, Y. & Dreier, J. W. Association of maternal antidepressant prescription during pregnancy with standardized test scores of Danish school-aged children. JAMA 326, 1725–1735 (2021).
Google Scholar
Brown, H. K. et al. Association between serotonergic antidepressant use during pregnancy and autism spectrum disorder in children. JAMA 317, 1544–1552 (2017).
Google Scholar
Biffi, A. et al. Use of antidepressants during pregnancy and neonatal outcomes: an umbrella review of meta-analyses of observational studies. J. Psychiatr. Res. 124, 99–108 (2020).
Google Scholar
Jiang, H. Y., Peng, C. T., Zhang, X. & Ruan, B. Antidepressant use during pregnancy and the risk of attention deficit hyperactivity disorder in the children: a meta-analysis of cohort studies. BJOG 125, 1077–1084 (2018).
Google Scholar
Cabrera-Vera, T. M., Garcia, F., Pinto, W. & Battaglia, G. Effect of prenatal fluoxetine (Prozac) exposure on brain serotonin neurons in prepubescent and adult male rat offspring. J. Pharmacol. Exp. Ther. 280, 138–145 (1997).
Google Scholar
Ansorge, M. S., Zhou, M., Lira, A., Hen, R. & Gingrich, J. A. Early-life blockade of the 5-HT transporter alters emotional behavior in adult mice. Science 306, 879–881 (2004).
Google Scholar
Holden, C. Neuroscience. Prozac treatment of newborn mice raises anxiety. Science 306, 792 (2004).
Google Scholar
Zanni, G. et al. Perinatal SSRI exposure impacts innate fear circuit activation and behavior in mice and humans. Nat. Commun. 16, 4002 (2025).
Google Scholar
Oberlander, T. F. et al. Hypothalamic-pituitary-adrenal (HPA) axis function in 3-month old infants with prenatal selective serotonin reuptake inhibitor (SSRI) antidepressant exposure. Early Hum. Dev. 84, 689–697 (2008).
Google Scholar
Hutchison, S. M., Mâsse, L. C., Pawluski, J. L. & Oberlander, T. F. Perinatal selective serotonin reuptake inhibitor (SSRI) and other antidepressant exposure effects on anxiety and depressive behaviors in offspring: a review of findings in humans and rodent models. Reprod. Toxicol. 99, 80–95 (2021).
Google Scholar
Hutchison, S. M., Masse, L. C., Pawluski, J. L. & Oberlander, T. F. Perinatal selective serotonin reuptake inhibitor (SSRI) effects on body weight at birth and beyond: a review of animal and human studies. Reprod. Toxicol. 77, 109–121 (2018).
Google Scholar
Gemmel, M. et al. Gestational stress and fluoxetine treatment differentially affect plasticity, methylation and serotonin levels in the PFC and hippocampus of rat dams. Neuroscience 327, 32–43 (2016).
Google Scholar
Appleton, A. A., Lin, B., Kennedy, E. M. & Holdsworth, E. A. Maternal depression and adverse neighbourhood conditions during pregnancy are associated with gestational epigenetic age deceleration. Epigenetics 17, 1905–1919 (2022).
Google Scholar
D’Anna-Hernandez, K. L., Aleman, B. & Flores, A. M. Acculturative stress negatively impacts maternal depressive symptoms in Mexican–American women during pregnancy. J. Affect. Disord. 176, 35–42 (2015).
Google Scholar
Sun, Y. et al. Association between urban green space and postpartum depression, and the role of physical activity: a retrospective cohort study in Southern California. Lancet Reg. Health Am. 21, 100462 (2023).
Google Scholar
Callaghan, B. L., McCormack, C., Kim, P. & Pawluski, J. L. Understanding the maternal brain in the context of the mental load of motherhood. Nat. Ment. Health 2, 764–772 (2024).
Google Scholar
Pawluski, J. L. & Gemmel, M. Perinatal SSRI medications and offspring hippocampal plasticity: interaction with maternal stress and sex. Hormones 17, 15–24 (2018).
Google Scholar
Rayen, I., van den Hove, D. L., Prickaerts, J., Steinbusch, H. W. & Pawluski, J. L. Fluoxetine during development reverses the effects of prenatal stress on depressive-like behavior and hippocampal neurogenesis in adolescence. PLoS ONE 6, e24003 (2011).
Google Scholar
Knaepen, L. et al. Developmental fluoxetine exposure normalizes the long-term effects of maternal stress on post-operative pain in Sprague–Dawley rat offspring. PLoS ONE 8, e57608 (2013).
Google Scholar
Gemmel, M. et al. Perinatal fluoxetine effects on social play, the HPA system, and hippocampal plasticity in pre-adolescent male and female rats: Interactions with pre-gestational maternal stress. Psychoneuroendocrinology 84, 159–171 (2017).
Google Scholar
Croen, L. A., Grether, J. K., Yoshida, C. K., Odouli, R. & Hendrick, V. Antidepressant use during pregnancy and childhood autism spectrum disorders. Arch. Gen. Psychiatry 68, 1104–1112 (2011).
Google Scholar
Sujan, A. C. et al. Associations of maternal antidepressant use during the first trimester of pregnancy with preterm birth, small for gestational age, autism spectrum disorder, and attention deficit hyperactivity disorder in offspring. JAMA 317, 1553–1562 (2017).
Google Scholar
Suarez, E. A. et al. Association of antidepressant use during pregnancy with risk of neurodevelopmental disorders in children. JAMA Intern. Med. 182, 1149–1160 (2022).
Google Scholar
Barker, L. C. et al. Decision-making about antidepressant medication use in pregnancy: a comparison between women making the decision in the preconception period versus in pregnancy. BMC Psychiatry 20, 54 (2020).
Google Scholar
Wisner, K. L. SSRI treatment during pregnancy: are we asking the right questions? Depress. Anxiety 27, 695–698 (2010).
Google Scholar
Walton, J. C., Aubrecht, T. G., Weil, Z. M., Leuner, B. & Nelson, R. J. Photoperiodic regulation of hippocampal neurogenesis in adult male white-footed mice (Peromyscus leucopus). Eur. J. Neurosci. 40, 2674–2679 (2014).
Google Scholar
Dupuis, M., Weir, K. R., Vidonscky Luthold, R., Panchaud, A. & Baggio, S. Social determinants of antidepressant continuation during pregnancy in the USA: findings from the ABCD cohort study. Arch. Womens Ment. Health 27, 1011–1018 (2024).
Google Scholar
Bliddal, M. et al. Prenatal antidepressant exposure and emotional disorders until age 22: a Danish register study. Child Adolesc. Psychiatry Ment. Health 17, 73 (2023).
Google Scholar
Rommel, A. S. et al. Long-term prenatal effects of antidepressant use on the risk of affective disorders in the offspring: a register-based cohort study. Neuropsychopharmacology 46, 1518–1525 (2021).
Google Scholar
Weikum, W. M., Oberlander, T. F., Hensch, T. K. & Werker, J. F. Prenatal exposure to antidepressants and depressed maternal mood alter trajectory of infant speech perception. Proc. Natl Acad. Sci. USA 109, 17221–17227 (2012).
Google Scholar
Weikum, W. M. et al. Prenatal serotonin reuptake inhibitor (SRI) antidepressant exposure and serotonin transporter promoter genotype (SLC6A4) influence executive functions at 6 years of age. Front. Cell. Neurosci. 7, 180 (2013).
Google Scholar
Dhaliwal, G. et al. Effects of maternal depression and prenatal SSRI exposure on executive functions and susceptibility to household chaos in 6-year-old children: prospective cohort study. BJPsych Open 6, e106 (2020).
Google Scholar
Gemmel, M. et al. Perinatal fluoxetine has enduring sexually differentiated effects on neurobehavioral outcomes related to social behaviors. Neuropharmacology 144, 70–81 (2019).
Google Scholar
Rayen, I., Steinbusch, H. W., Charlier, T. D. & Pawluski, J. L. Developmental fluoxetine exposure facilitates sexual behavior in female offspring. Psychopharmacology 231, 123–133 (2014).
Google Scholar
Rayen, I., Gemmel, M., Pauley, G., Steinbusch, H. W. & Pawluski, J. L. Developmental exposure to SSRIs, in addition to maternal stress, has long-term sex-dependent effects on hippocampal plasticity. Psychopharmacology 232, 1231–1244 (2015).
Google Scholar
Bayrampour, H., Kapoor, A., Bunka, M. & Ryan, D. The risk of relapse of depression during pregnancy after discontinuation of antidepressants: a systematic review and meta-analysis. J. Clin. Psychiatry 81, 19r13134 (2020).
Google Scholar
Sharma, V., Sharkey, K. M., Palagini, L., Mazmanian, D. & Thomson, M. Preventing recurrence of postpartum depression by regulating sleep. Expert Rev. Neurother. 23, 1–9 (2023).
Google Scholar
Mason, G. M., Cohen, Z. L., Obeysekare, J., Saletin, J. M. & Sharkey, K. M. Preliminary report: sleep duration during late pregnancy predicts postpartum emotional responses among parents at risk for postpartum depression. Sleep Adv. 5, zpae068 (2024).
Google Scholar
Leistikow, N. et al. Prescribing sleep: an overlooked treatment for postpartum depression. Biol. Psychiatry 92, e13–e15 (2022).
Google Scholar
Ho, S. S. et al. Potential neural mediators of Mom Power parenting intervention effects on maternal intersubjectivity and stress resilience. Front. Psychiatry 11, 568824 (2020).
Google Scholar
Klimes-Dougan, B. et al. Structural and functional neural correlates of treatment response for interpersonal psychotherapy for depressed adolescents. J. Clin. Med. 11, 1878 (2022).
Google Scholar
Haller, S. P. et al. Normalization of fronto-parietal activation by cognitive–behavioral therapy in unmedicated pediatric patients with anxiety disorders. Am. J. Psychiatry 181, 201–212 (2024).
Google Scholar
Waters, C. S., Hay, D. F., Simmonds, J. R. & van Goozen, S. H. Antenatal depression and children’s developmental outcomes: potential mechanisms and treatment options. Eur. Child Adolesc. Psychiatry 23, 957–971 (2014).
Google Scholar
Turpyn, C. C. et al. Affective neural mechanisms of a parenting-focused mindfulness intervention. Mindfulness 12, 392–404 (2021).
Google Scholar
Muzik, M. et al. Mom Power: preliminary outcomes of a group intervention to improve mental health and parenting among high-risk mothers. Arch. Womens Ment. Health 18, 507–521 (2015).
Google Scholar
Letourneau, N. L., Dennis, C. L., Cosic, N. & Linder, J. The effect of perinatal depression treatment for mothers on parenting and child development: a systematic review. Depress. Anxiety 34, 928–966 (2017).
Google Scholar
Warriner, S., Crane, C., Dymond, M. & Krusche, A. An evaluation of mindfulness-based childbirth and parenting courses for pregnant women and prospective fathers/partners within the UK NHS (MBCP-4-NHS). Midwifery 64, 1–10 (2018).
Google Scholar
Shah, L. et al. Effectiveness of peer support interventions in improving mothers’ psychosocial well-being during the perinatalperiod: a systematic review and meta-analysis. Worldviews Evid. Based Nurs. 21, 652–664 (2024).
Google Scholar
Vigod, S. N. et al. Transcranial direct current stimulation (tDCS) for depression in pregnancy: A pilot randomized controlled trial. Brain Stimul. 12, 1475–1483 (2019).
Google Scholar
Sambrook Smith, M., Lawrence, V., Sadler, E. & Easter, A. Barriers to accessing mental health services for women with perinatal mental illness: systematic review and meta-synthesis of qualitative studies in the UK. BMJ Open 9, e024803 (2019).
Google Scholar
Webb, R. et al. Meta-review of the barriers and facilitators to women accessing perinatal mental healthcare. BMJ Open 13, e066703 (2023).
Google Scholar
Gentile, S. & Fusco, M. L. Untreated perinatal paternal depression: effects on offspring. Psychiatry Res. 252, 325–332 (2017).
Google Scholar
Fleischman, S. J. ACOG statement on the benefit of access to SSRIs during pregnancy. ACOG (21 July 2025).
Oberlander, T. F., Gingrich, J. A. & Ansorge, M. S. Sustained neurobehavioral effects of exposure to SSRI antidepressants during development: molecular to clinical evidence. Clin. Pharmacol. Ther. 86, 672–677 (2009).
Google Scholar
link